InvestSMART

SomnoMed Limited (ASX: SOM) - Announcements

Current share price for SOM : $0.460 0.02 (4.17%)+

ASX company news and announcements for SomnoMed Limited (SOM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All SomnoMed Limited (SOM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than SomnoMed Limited (SOM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for SomnoMed Limited (SOM)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$101 FY25 Half Year Results 28 Feb 2025 8:47AM $0.600 $0.460 fallen by 23.33%
$101 Half Yearly Report and Accounts 28 Feb 2025 8:41AM $0.600 $0.460 fallen by 23.33%
$101 H1FY25 Financial Results webinar details 11 Feb 2025 9:01AM $0.640 $0.460 fallen by 28.13%
$101 Notification regarding unquoted securities - SOM 29 Jan 2025 6:53PM $0.675 $0.460 fallen by 31.85%
$101 Quarterly Appendix 4C Cash Flow Report 24 Jan 2025 8:44AM $0.600 $0.460 fallen by 23.33%
$101 FY25 Guidance Update and Quarterly Report 24 Jan 2025 8:44AM $0.600 $0.460 fallen by 23.33%
$101 Initial Director's Interest Notice 20 Jan 2025 9:25AM $0.465 $0.460 fallen by 1.08%
$101 Appointment of a Director 20 Jan 2025 9:17AM $0.465 $0.460 fallen by 1.08%
$101 Change in substantial shareholding from AEF 16 Dec 2024 10:22AM $0.485 $0.460 fallen by 5.15%
$101 Change of Director's Interest Notice 5 Dec 2024 6:14PM $0.455 $0.460 risen by 1.10%
$101 Change of Director's Interest Notice 5 Dec 2024 6:02PM $0.455 $0.460 risen by 1.10%
$101 Change of Director's Interest Notice 5 Dec 2024 6:01PM $0.455 $0.460 risen by 1.10%
$101 Notification regarding unquoted securities - SOM 5 Dec 2024 5:59PM $0.455 $0.460 risen by 1.10%
$101 AGM results 27 Nov 2024 3:16PM $0.380 $0.460 risen by 21.05%
$101 AGM Chairman & co-CEO addresses 27 Nov 2024 9:42AM $0.270 $0.460 risen by 70.37%
$101 Investor Presentation AGM 27 Nov 2024 9:39AM $0.270 $0.460 risen by 70.37%
$101 FY25 Guidance Upgrade and Appointment of CFO 27 Nov 2024 9:38AM $0.270 $0.460 risen by 70.37%
$101 Quarterly Appendix 4C Cash Flow Report 23 Oct 2024 9:04AM $0.325 $0.460 risen by 41.54%
$101 Quarterly Activities Report 23 Oct 2024 9:03AM $0.325 $0.460 risen by 41.54%
$101 Annual General Meeting Proxy Form 17 Oct 2024 4:47PM $0.320 $0.460 risen by 43.75%
$101 Notice of Annual General Meeting 17 Oct 2024 4:47PM $0.320 $0.460 risen by 43.75%
$101 Initial Director's Interest Notice 8 Oct 2024 11:29AM $0.365 $0.460 risen by 26.03%
$101 Final Director's Interest Notice 8 Oct 2024 11:29AM $0.365 $0.460 risen by 26.03%
$101 Rest Assure - US Food and Drug Authority (FDA) Update 7 Oct 2024 8:50AM $0.390 $0.460 risen by 17.95%
$101 Director Appointment/Resignation 3 Oct 2024 9:49AM $0.400 $0.460 risen by 15%

51 - 75 of 675 results

Page 3 of 27

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.